Showing results (1-10 of 344) with videos related to
Sort By:
Pageof 35
The Biochemical Journal|October 25, 2017
Therapeutics targeting Bcl-2 in hematological malignanciesAstrid Ruefli-Brasse, John C ReedPlos One|January 10, 2013
Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodiesOlivier Nolan-Stevaux, Wendy Zhong, Stacey Culp, et al.Cancer Discovery|March 17, 2018
Tissue-Specific Immunoregulation: A Call for Better Understanding of the "Immunostat" in the Context of CancerWilliam Pao, Chia-Huey Ooi, Fabian Birzele, et al.Plos One|July 11, 2013
Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor EngraftmentOlivier Nolan-Stevaux, Donato Tedesco, Seamus Ragan, et al.Neoplasia (New York, N.Y.)|April 9, 2008
The growth factor Midkine antagonizes VEGF signaling in vitro and in vivoEdward Htun van der Horst, Brendon T Frank, Lawrence Chinn, et al.Blood|March 26, 2008
Bcl-2-family proteins and hematologic malignancies: history and future prospectsJohn C ReedOncology (Williston Park, N.Y.)|January 18, 2005
Apoptosis mechanisms: implications for cancer drug discoveryJohn C ReedNature Clinical Practice. Oncology|July 11, 2006
Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanismsJohn C ReedPigment Cell & Melanoma Research|November 29, 2011
NLRP1, a regulator of innate immunity associated with vitiligoAndrea D'Osualdo, John C ReedPageof 35